Walleye Trading
ONC icon

Walleye Trading’s BeOne Medicines Ltd ONC Stock Holding History

Walleye Trading’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-224
Closed -$40.3K – 5578
2023
Q3 		$40.3K Buy
+224
New +$44.3K ﹤0.01% 4255
2020
Q1 		– Sell
-985
Closed -$163K – 4691
2019
Q4 		$163K Buy
+985
New +$164K ﹤0.01% 3297
2019
Q2 		– Sell
-383
Closed -$48.6K – 4587
2019
Q1 		$51K Buy
+383
New +$51.7K ﹤0.01% 3712
2018
Q4 		– Sell
-522
Closed -$69.2K – 5426
2018
Q3 		$90K Buy
+522
New +$87.8K ﹤0.01% 4263

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Walleye Trading's ONC Position: Q4 2023 in Review

Walleye Trading sold out of BeOne Medicines Ltd (ONC) in Q4 2023, closing a stake of 224 shares — an estimated $40.3K sold.

Walleye Trading first reported a position in ONC in Q3 2018 and held it in 4 quarters. The position peaked at $163K in Q4 2019. 204 funds tracked by Wall St. Rank hold ONC as of Q4 2023.

  • Walleye Trading reported no remaining BeOne Medicines Ltd position as of Q4 2023 after selling out during the quarter.
  • Walleye Trading sold 224 BeOne Medicines Ltd shares in Q4 2023, an estimated $40.3K.
  • Walleye Trading first reported a position in BeOne Medicines Ltd in Q3 2018 and held it in 4 quarters.
  • Walleye Trading's BeOne Medicines Ltd position peaked at $163K in Q4 2019.
  • 204 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2023.

Based on Walleye Trading's 13F filing for Q4 2023, filed 14 Feb 2024.